Project deliverable Open Access

FAIRplus: D1.2 Selection criteria and guidelines for data sources from IMI projects and EFPIA internal databases

Gribbon, Philip; Gu, Wei; Sanz, Ferran; Ioannidis, Vassilios; Engkvist, Ola; Henderson, David; Reilly, Dorothy; Rocca-Serra, Philippe; Zaliani, Andrea; Witt, Gesa; Kohler, Manfred; Giessmann, Robert


MARC21 XML Export

<?xml version='1.0' encoding='UTF-8'?>
<record xmlns="http://www.loc.gov/MARC21/slim">
  <leader>00000nam##2200000uu#4500</leader>
  <datafield tag="653" ind1=" " ind2=" ">
    <subfield code="a">FAIRplus</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
    <subfield code="a">FAIRification</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
    <subfield code="a">IMI2 JU</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
    <subfield code="a">Innovative Medicines Initiative</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
    <subfield code="a">Datasets</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
    <subfield code="a">Guidelies</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
    <subfield code="a">H2020</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
    <subfield code="a">Societal priorities</subfield>
  </datafield>
  <controlfield tag="005">20200120172742.0</controlfield>
  <datafield tag="500" ind1=" " ind2=" ">
    <subfield code="a">This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No. 802750. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation and EFPIA companies.</subfield>
  </datafield>
  <controlfield tag="001">3596024</controlfield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">University of Luxembourg</subfield>
    <subfield code="a">Gu, Wei</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Barcelona Supercomputing Centre</subfield>
    <subfield code="a">Sanz, Ferran</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Swiss Institute of Bioinformatics</subfield>
    <subfield code="a">Ioannidis, Vassilios</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">AstraZeneca AB</subfield>
    <subfield code="a">Engkvist, Ola</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Bayer</subfield>
    <subfield code="a">Henderson, David</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Novartis Pharmaceuticals</subfield>
    <subfield code="a">Reilly, Dorothy</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">University of Oxford</subfield>
    <subfield code="a">Rocca-Serra, Philippe</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Fraunhofer E.V</subfield>
    <subfield code="a">Zaliani, Andrea</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Fraunhofer E.V</subfield>
    <subfield code="a">Witt, Gesa</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Fraunhofer E.V</subfield>
    <subfield code="a">Kohler, Manfred</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Bayer</subfield>
    <subfield code="a">Giessmann, Robert</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2=" ">
    <subfield code="s">1077867</subfield>
    <subfield code="z">md5:723a2e053ce82882f76bb0f34da246c4</subfield>
    <subfield code="u">https://zenodo.org/record/3596024/files/D1.2_FAIRplus_Selection criteria and guidelines for data from IMI projects and EFPIA.pdf</subfield>
  </datafield>
  <datafield tag="542" ind1=" " ind2=" ">
    <subfield code="l">open</subfield>
  </datafield>
  <datafield tag="260" ind1=" " ind2=" ">
    <subfield code="c">2019-12-31</subfield>
  </datafield>
  <datafield tag="909" ind1="C" ind2="O">
    <subfield code="p">openaire</subfield>
    <subfield code="o">oai:zenodo.org:3596024</subfield>
  </datafield>
  <datafield tag="100" ind1=" " ind2=" ">
    <subfield code="u">Fraunhofer E.V</subfield>
    <subfield code="a">Gribbon, Philip</subfield>
  </datafield>
  <datafield tag="245" ind1=" " ind2=" ">
    <subfield code="a">FAIRplus: D1.2 Selection criteria and guidelines for data sources from IMI projects and EFPIA internal databases</subfield>
  </datafield>
  <datafield tag="536" ind1=" " ind2=" ">
    <subfield code="c">802750</subfield>
    <subfield code="a">FAIRplus</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
    <subfield code="u">https://creativecommons.org/licenses/by/4.0/legalcode</subfield>
    <subfield code="a">Creative Commons Attribution 4.0 International</subfield>
  </datafield>
  <datafield tag="650" ind1="1" ind2="7">
    <subfield code="a">cc-by</subfield>
    <subfield code="2">opendefinition.org</subfield>
  </datafield>
  <datafield tag="520" ind1=" " ind2=" ">
    <subfield code="a">&lt;p&gt;Creating selection criteria and guidelines, to aid identification of IMI datasets with the potential to generate high societal impact upon FAIRification, is an important goal of FAIRplus. This deliverable report describes the process put in place to identify, evaluate and select projects. Two thirds of projects to be addressed by FAIRplus will cover societal priorities of H2020, namely; 1) promoting healthy ageing&lt;a&gt;&lt;sup&gt;&lt;sup&gt;[1]&lt;/sup&gt;&lt;/sup&gt;&lt;/a&gt;; 2) addressing chronic diseases; 3) neurodegenerative diseases and 4) emergence of antibiotic resistance. In addition, we have identified cross-cutting projects &amp;ldquo;Cross&amp;rdquo; which provide tools&amp;nbsp;&amp;nbsp;such as cell lines, biomarkers and animal models, which enable research progression in the primary priority areas. In the first period, some 25 projects have been identified based on the application of the criteria and discussions are ongoing with these consortia representatives&amp;nbsp;&amp;nbsp;in order to provide a steady flow of datasets into FAIRplus.&lt;/p&gt;

&lt;p&gt;&amp;nbsp;&lt;/p&gt;

&lt;p&gt;&lt;a&gt;&lt;sup&gt;&lt;sup&gt;[1]&lt;/sup&gt;&lt;/sup&gt;&lt;/a&gt;&amp;nbsp;see&amp;nbsp;&amp;nbsp;&lt;a href="http://ec.europa.eu/programmes/horizon2020/en/h2020-section/health-demographic-change-and-wellbeing"&gt;http://ec.europa.eu/programmes/horizon2020/en/h2020-section/health-demographic-change-and-wellbeing&lt;/a&gt;&lt;/p&gt;</subfield>
  </datafield>
  <datafield tag="773" ind1=" " ind2=" ">
    <subfield code="n">doi</subfield>
    <subfield code="i">isVersionOf</subfield>
    <subfield code="a">10.5281/zenodo.3596023</subfield>
  </datafield>
  <datafield tag="024" ind1=" " ind2=" ">
    <subfield code="a">10.5281/zenodo.3596024</subfield>
    <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">publication</subfield>
    <subfield code="b">deliverable</subfield>
  </datafield>
</record>
275
198
views
downloads
All versions This version
Views 275275
Downloads 198198
Data volume 213.4 MB213.4 MB
Unique views 252252
Unique downloads 183183

Share

Cite as